Age-related decline in melatonin contributes to enhanced osteoclastogenesis via disruption of redox homeostasis
Authors:
Open Access
- 12 January 2024
- journal article
- research article
- Published by Springer Nature in Molecular Medicine
- Vol. 30 (1) , 1-14
Abstract
Background: Increased oxidative stress contributes to enhanced osteoclastogenesis and age-related bone loss. Melatonin (MT) is an endogenous antioxidant and declines with aging. However, it was unclear whether the decline of MT was involved in the enhanced osteoclastogenesis during the aging process. Methods: The plasma level of MT, oxidative stress status, bone mass, the number of bone marrow-derived monocytes (BMMs) and its osteoclastogenesis were analyzed in young (3-month old) and old (18-month old) mice (n = 6 per group). In vitro, BMMs isolated from aged mice were treated with or without MT, followed by detecting the change of osteoclastogenesis and intracellular reactive oxygen species (ROS) level. Furthermore, old mice were treated with MT for 2 months to investigate the therapeutic effect. Results: The plasma level of MT was markedly lower in aged mice compared with young mice. Age-related decline in MT was accompanied by enhanced oxidative stress, osteoclastogenic potential and bone loss. MT intervention significantly suppressed the receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis, decreased intracellular ROS and enhanced antioxidant capacity of BMMs from aged mice. MT supplementation significantly attenuated oxidative stress, osteoclastogenesis, bone loss and deterioration of bone microstructure in aged mice. Conclusions: These results suggest that age-related decline of MT enhanced osteoclastogenesis via disruption of redox homeostasis. MT may serve as a key regulator in osteoclastogenesis and bone homeostasis, thereby highlighting its potential as a preventive agent for age-related bone loss.Keywords
All Related Versions
Funding Information
- Natural Science Foundation of Guangdong Province (2019A1515012075)
This publication has 52 references indexed in Scilit:
- From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of OsteoporosisEndocrine Reviews, 2010
- Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen speciesJournal of Pineal Research, 2008
- Melatonin at pharmacological doses enhances human osteoblastic differentiation in vitro and promotes mouse cortical bone formation in vivoJournal of Pineal Research, 2006
- Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and bindingBlood, 2006
- Aging Increases Stromal/Osteoblastic Cell-Induced Osteoclastogenesis and Alters the Osteoclast Precursor Pool in the MouseJournal of Bone and Mineral Research, 2005
- A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiationBlood, 2005
- The basic physiology and pathophysiology of melatoninSleep Medicine Reviews, 2005
- Mitochondria, Oxidants, and AgingCell, 2005
- Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosisThe FASEB Journal, 2004
- Age-related bone loss in mice is associated with an increased osteoclast progenitor poolBone, 1994